Jason S. Fisherman, Director at Aegerion Pharmaceuticals, Inc. (AEGR), bought 4,270 shares at $9.50 ($24K) on 2010-10-27, disclosed to the SEC on 2010-10-27.
Open-market purchase of $24k AEGR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,245 | $0 | 0.0% |
| 2 | $7.60 | 2,286 | $17K | 71.2% |
| 3 | $9.50 | 739 | $7K | 28.8% |
| Total | $5.71 avg | 4,270 | $24K | 100% |
| Filing → |
| ACHN | BUY | 2013-08-14 | $34K | — | Filing → |
| ACHN | BUY | 2013-06-25 | $76K | — | Filing → |
| ACHN | BUY | 2013-06-05 | $79K | — | Filing → |